These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 13794009)

  • 1. Radiation dosimetry in Hiroshima and Nagasaki atomic-bomb survivors.
    ARAKAWA ET
    N Engl J Med; 1960 Sep; 263():488-93. PubMed ID: 13794009
    [No Abstract]   [Full Text] [Related]  

  • 2. Workshop Report on Atomic Bomb Dosimetry--Review of Dose Related Factors for the Evaluation of Exposures to Residual Radiation at Hiroshima and Nagasaki.
    Kerr GD; Egbert SD; Al-Nabulsi I; Bailiff IK; Beck HL; Belukha IG; Cockayne JE; Cullings HM; Eckerman KF; Granovskaya E; Grant EJ; Hoshi M; Kaul DC; Kryuchkov V; Mannis D; Ohtaki M; Otani K; Shinkarev S; Simon SL; Spriggs GD; Stepanenko VF; Stricklin D; Weiss JF; Weitz RL; Woda C; Worthington PR; Yamamoto K; Young RW
    Health Phys; 2015 Dec; 109(6):582-600. PubMed ID: 26509626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to Atomic Bomb Radiation and Age-Related Macular Degeneration in Later Life: The Hiroshima-Nagasaki Atomic Bomb Survivor Study.
    Itakura K; Takahashi I; Nakashima E; Yanagi M; Kawasaki R; Neriishi K; Wang JJ; Wong TY; Hida A; Ohishi W; Kiuchi Y
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5401-6. PubMed ID: 26275137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Theoretical background of the Dosimetry System 86 (D586).
    Kosako T
    J Radiat Res; 1991 Mar; 32 Suppl():11-9. PubMed ID: 1762097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cover-up of the effects of internal exposure by residual radiation from the atomic bombing of Hiroshima and Nagasaki.
    Sawada S
    Med Confl Surviv; 2007; 23(1):58-74. PubMed ID: 17370859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system.
    Otake M; Schull WJ
    Radiat Res; 1990 Jan; 121(1):3-13. PubMed ID: 2300666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects and status of the dosimetry system for atomic bomb survivor cohort study conducted at Research Institute for Radiation Biology and Medicine of Hiroshima University.
    Hirota S; Yasuda H; Kawakami H; Yoshinaga S
    J Radiat Res; 2021 May; 62(Supplement_1):i107-i113. PubMed ID: 33978168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. The Dosimetry System 1986 (DS86) and the Tentative Dosimetry System 1965 (T65D): how do they compare, what is left to do?
    Thiessen JW; Kaul DC
    J Radiat Res; 1991 Mar; 32 Suppl():1-10. PubMed ID: 1762093
    [No Abstract]   [Full Text] [Related]  

  • 9. RELATIVE BIOLOGICAL EFFECTIVENESS OF NEUTRONS DERIVED FROM THE EXCESS RELATIVE RISK MODEL WITH THE ATOMIC BOMB SURVIVORS DATA MANAGED BY HIROSHIMA UNIVERSITY.
    Satoh K; Yasuda H; Kawakami H; Tashiro S
    Radiat Prot Dosimetry; 2018 Aug; 180(1-4):346-350. PubMed ID: 29036656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.
    Hara N; Satoh K; Otani K; Kawakami H; Ohtaki M
    Hiroshima J Med Sci; 2016 Sep; 65(2):45-51. PubMed ID: 29989684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki.
    Kato K; Antoku S; Russell WJ; Fujita S; Pinkston JA; Hayabuchi N; Hoshi M; Kodama K
    Radiat Res; 1998 Jun; 149(6):614-24. PubMed ID: 9611100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The grave is wide: the Hibakusha of Hiroshima and Nagasaki and the legacy of the Atomic Bomb Casualty Commission and the Radiation Effects Research Foundation.
    O'Malley GF
    Clin Toxicol (Phila); 2016 Jul; 54(6):526-30. PubMed ID: 27158765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice of model and uncertainties of the gamma-ray and neutron dosimetry in relation to the chromosome aberrations data in Hiroshima and Nagasaki.
    Rühm W; Walsh L; Chomentowski M
    Radiat Environ Biophys; 2003 Jul; 42(2):119-28. PubMed ID: 12844221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrons at Hiroshima: how their disappearance affected risk estimates.
    Ellett WH
    Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The observed relationship between the occurrence of acute radiation effects and leukemia mortality among A-bomb survivors.
    Neriishi K; Stram DO; Vaeth M; Mizuno S; Akiba S
    Radiat Res; 1991 Feb; 125(2):206-13. PubMed ID: 1996379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development of fetal dosimetry and its application to A-bomb survivors exposed in utero.
    Chen J
    Radiat Prot Dosimetry; 2012 Mar; 149(1):60-6. PubMed ID: 21816724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Health effects of atomic bomb radiation].
    Shigematsu I
    Rinsho Byori; 1994 Apr; 42(4):313-9. PubMed ID: 8176838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Initial-dose Dependency of Cerebrovascular Disease Mortality among Female Survivors of the Hiroshima Atomic Bomb Exposed in Teens: A Cohort Study, 1970-2010.
    Matsuba J; Otani K; Satoh K; Kawakami H; Ohtaki M
    Hiroshima J Med Sci; 2016 Sep; 65(2):35-43. PubMed ID: 29989683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [REPORT OF SURVEYS OF NAGASAKI AND HIROSHIMA ATOMIC BOMB CASUALTIES (COMPARISON OF NAGASAKI AND HIROSHIMA)].
    FUKUDA C
    Nagasaki Igakkai Zasshi; 1963 Dec; 38():SUPPL:61-4. PubMed ID: 14147511
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
    Iwanaga M; Tomonaga M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.